Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39017 | 0.86 | POLB (0.34) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL2264844 | 0.86 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL5455454 | 0.85 | POLB (0.33) | POLBCYP2C9CYP2C19CYP1A2 | |
| SCHEMBL27974118 | 0.75 | ALDH1A1 (0.52) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL8919537 | 0.74 | — | — | |
| SCHEMBL4201014 | 0.72 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL29398621 | 0.72 | SMN1; SMN2 (0.36) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL77703 | 0.71 | POLB (0.36) | POLB | |
| SCHEMBL1664850 | 0.68 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL373554 | 0.68 | SMN1; SMN2 (0.35) | SMN1; SMN2ALDH1A1CA2POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306567-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORP (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-20240317967-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| US-20240141094-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORPORATION (JP) | 2024-05-02 | — | — | US | disclosed |
| US-20240084065-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | ADEKA CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-4306567-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORPORATION (JP) | 2024-01-17 | — | — | EP | disclosed |
| EP-4289883-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-2848646-B1 | CELLULOSE RESIN COMPOSITION | ADEKA CORP (JP) | 2023-11-08 | — | — | EP | disclosed |
| US-10578774-B2 | Retardation-increasing agent, cellulose-based resin composition using same, and film | ADEKA CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| EP-2868694-B1 | CELLULOSE ESTER-BASED RESIN COMPOSITION | ADEKA CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-20190048135-A1 | MODIFIER FOR RESIN, RESIN COMPOSITION, AND FILM IN WHICH SAME IS USED | ADEKA CORPORATION (JP) | 2019-02-14 | — | — | US | disclosed |
| US-20110319537-A1 | VINYL CHLORIDE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110288218-A1 | VINYL CHLORIDE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110277664-A1 | CELLULOSE RESIN COMPOSITION AND CELLULOSE RESIN FILM | ADEKA CORPORATION (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20110197784-A1 | CELLULOSE RESIN COMPOSITION AND CELLULOSE RESIN FILM | ADEKA CORPORATION (JP) | 2011-08-18 | — | — | US | disclosed |
| US-20110015322-A1 | CELLULOSE RESIN COMPOSITION AND CELLULOSE RESIN FILM | ADEKA CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20110003917-A1 | POLYLACTIC ACID RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2253667-A1 | POLYLACTIC ACID RESIN COMPOSITION | Adeka Corporation (JP) | 2010-11-24 | — | — | EP | disclosed |
| EP-2045291-A1 | VINYL CHLORIDE RESIN COMPOSITION | Adeka Corporation (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-20030162870-A1 | Flame-retardant resin composition | ASAHI DENKA CO., LTD. (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1304350-A1 | Flame-retardant resin composition | Asahi Denka Co., Ltd. (JP) | 2003-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240084065-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | PSMC6, CAND1, RBX1 | SMN1; SMN2 508/4885ALDH1A1 709/4885CA2 2505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.